A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma

חו"ל (דורש נסיעה)מגייס משתתפים

מצבים רפואיים

Neuropathy · Urothelial Carcinoma · Metastatic Urothelial Carcinoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Samuel Funt, MD) · 646-888-4770
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

    Contact: Study coordinator (Samuel Funt, MD) · 646-888-4770
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

    Contact: Study coordinator (Samuel Funt, MD) · 646-888-4770
  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities), Commack, New York, United States

    Contact: Study coordinator (Samuel Funt, MD) · 646-888-4770
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

    Contact: Study coordinator (Samuel Funt, MD) · 646-888-4770
  • Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York, New York, United States

    Contact: Study coordinator (Samuel Funt, MD) · 646-888-4770
  • Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre, New York, United States

    Contact: Study coordinator (Samuel Funt, MD) · 646-888-4770
מובילי המחקר
  • Samuel Funt, MD

    Principal Investigator

    Memorial Sloan Kettering Cancer Center